about
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancerThe role of receptor internalization in CD95 signaling.A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndromeAstrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study.Membrane trafficking of death receptors: implications on signallingThe role of CD95 and CD95 ligand in cancerThe naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathwayIn vivo imaging of hierarchical spatiotemporal activation of caspase-8 during apoptosisDimerization of LT R by LT 1 2 is necessary and sufficient for signal transductionMDC-L, a novel metalloprotease disintegrin cysteine-rich protein family member expressed by human lymphocytesThe lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serumMatrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosisLethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNADrug development against metastasis-related genes and their pathways: A rationale for cancer therapyA Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis.Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cells.Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL.Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets.Use of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis.The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammationMolecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptorsInvolvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis.ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis.Structure and function of Fas/Fas ligand.Safety and antitumor activity of recombinant soluble Apo2 ligand.Fas and Fas ligand in gut and liver.Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase.Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.Fas/FasL interaction of nucleus pulposus and cancer cells with the activation of caspases.Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria.Ectodermal dysplasias: not only 'skin' deep.Fas activation induces renal tubular epithelial cell beta 8 integrin expression and function in the absence of apoptosis.The many roles of FAS receptor signaling in the immune systemApoptosis and its clinical impact.
P2860
Q22008593-8E40F961-89BE-4173-91F4-5122F90B07A6Q24305510-E31EA0D1-709C-40AD-BBDC-3B9A06A2D002Q24533465-0DA83412-477D-4DB3-ADBF-4C483D548A30Q24685217-BF5FD23A-C145-46CB-BC5B-0260C529FF56Q25255834-4746758A-E074-4C59-AD66-E3730D050427Q26852802-1854A3FF-D4C1-4C10-85FF-6F88D220A92BQ26995847-E9001B15-2A46-46B6-A5C3-001A47CF84F4Q27321306-CDC43DA4-7977-4FBC-BBC3-A753476E40AFQ27334399-45C2C473-6483-4F8C-92F3-EF17A2EDBEE4Q27680632-6900F194-8D23-4353-9B49-77A520555687Q28145371-ABB3AB3A-DC2D-49B5-8E4E-B43FC5A4721CQ28207811-2C0F3366-A695-41E8-9555-0FD2466A8C1EQ28281103-0AC4C547-3ACB-4942-B800-B94DC0E192BAQ28344462-79C0DCE6-8810-40FD-AAF9-4788EC42AABCQ28587147-4DED96ED-E700-415C-A1E3-463AECF78CD0Q29010479-EA8E3CBD-CE13-4FB7-9739-13F3B6CCDC8FQ30252954-C3F6A498-31A1-4F8E-98F8-4510FAD86DD8Q30273613-54AF9752-F25E-430D-BAC0-F63B794F4CDAQ33183537-B5B1C671-38CC-42CE-B659-92B554E379E9Q33214095-74BFD9ED-83C7-46B9-9AFC-B4F0D87A43F8Q33289418-1F42226E-26EF-4247-A38F-CBE8177A2E11Q33402525-746C3F83-848F-45A8-B1CF-01B5AB081C63Q33586182-0AFD4CB0-0177-44A0-9130-2ADAC638DF63Q33607280-22DE1BCE-7DD7-42C3-B570-4130C9C362EEQ33784802-CFD52939-68C5-4E94-8B6D-961E3FEC031AQ33801352-7D619A89-2E27-4FDF-A3E5-50619EB2AFD5Q33805782-918843DA-9DC2-4D94-886A-A20BAB3DB074Q33811723-AFDACAD9-DF18-4291-8E66-51027BCB7B81Q33855449-2B645342-804D-4D10-A361-96EAA70D4CA0Q33860215-CC437F95-B584-420F-82F2-A3C634A34182Q33867607-95BFF7A9-8C71-4599-A1D3-2462554F0CD0Q33880837-9E21F4A8-DE5C-48DD-96EA-AF6E742B6720Q33891000-3D52EEE4-F7A4-4B1A-90A8-48EA51E8E8ECQ33945271-9F37FADD-A5F5-4F4F-A83C-E6E3F759BB5FQ33969742-DD8BEE55-341C-49CA-ACDE-5A15B734B725Q34004507-AC5F0B17-AFE0-4884-BFA2-321CC78966C7Q34125646-C2B3BBE4-9F24-4237-BAE1-E2625897A03BQ34151685-37DD4DD8-F8C3-4C74-94EC-7F90FFFCC1E9Q34205697-BEE0F413-5CB2-46FA-91A1-0DD5818B8040Q34214558-28C02D67-13C7-46D6-B49D-88B63211DE41
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Downregulation of Fas ligand by shedding.
@en
type
label
Downregulation of Fas ligand by shedding.
@en
prefLabel
Downregulation of Fas ligand by shedding.
@en
P2093
P2860
P356
P1433
P1476
Downregulation of Fas ligand by shedding.
@en
P2093
P2860
P2888
P356
10.1038/NM0198-031
P407
P577
1998-01-01T00:00:00Z